Case Report
Copyright ©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 7, 2007; 13(13): 2007-2010
Published online Apr 7, 2007. doi: 10.3748/wjg.v13.i13.2007
Table 1 Main characteristics of 8 liver transplant recipients with PRCA due to PVB19 infection
Case12345678
Age when anemia (yr)1.84.71.41.426434138
SexFFMMFMMM
ImmunosuppressionFKCsAFKFKAZA + FK + CoAZA + FKCsA + AZA + CoFK + MMF + Co
Anemia onset (month after LTx)2346830111 d3 wk
Lowest Hb (g/L)4673697033547521
Reticulocyte count00.40%00.80%00ND0.40%
Other manifestationErythema infectiosumNoneFever, stridor, leucopeniaNoneArthralgiaNoneFeverNone
Bone marrow biopsyNDNDGPNDGPGPNDGP
PVB19 IgMPPPPPPNND
PVB19 IgGPPNPPNPND
PVB19 DNANDNDNDNDPPPP
TreatmentIVIG: 1 g/d × 3 dIVIG: 0.4 g/kg per day × 10 d, 12 coursesIVIG: 0.4 g/kg per day × 5 dIVIG: 0.4 g/kg per day × 5 dIVIG: 0.4 g/kg per day × 10 d, plasmapheresisIVIGNDIVIG: 0.4 g/kg per day × 5 d × 2 courses
OutcomeHb normalized 4 wk after IVIGHb normalized 2 wk after IVIGHb normalized 4 wk after IVIGHb normalized 2 wk after IVIGHb normalized and virus DNA negative 16 wk after plasmapheresisHb normalized and virus DNA negative 3 wk after IVIGNDHb normalized 12 wk after IVIG with long-term low-level viral load and virus DNA negative 5 mo after Hb normalization
Reference[16][16][16][16][17][18][19]This case